| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/11/2006 | EP1613644A1 Peg-physiologically active polypeptide homodimer complex having prolonged in vivo half-life and process for the preparation thereof |
| 01/11/2006 | EP1156817A4 Controlling protein levels in eucaryotic organisms |
| 01/11/2006 | EP0787142B1 Neurturin and related growth factors |
| 01/11/2006 | EP0776972B1 GENE CODING FOR IgG-Fc-BINDING PROTEIN |
| 01/11/2006 | EP0771352B1 Nontypable haemophilus influenzae lkp tip adhesin protein and nucleic acid |
| 01/11/2006 | CN1720336A Use of A33 antigens and JAM-IT |
| 01/11/2006 | CN1720326A Method of strengthening foreign epitope presentation by MHC class I by inhibiting TAP activity |
| 01/11/2006 | CN1718587A Ant CD20 chimeric antibody |
| 01/11/2006 | CN1235911C Multiple cytokine-antibody complexes |
| 01/11/2006 | CN1235910C Target-specific cytotoxin chimeric with short-peptide harmone |
| 01/10/2006 | US6984720 cytotoxic t lymphocytes; immunology |
| 01/10/2006 | US6984384 A biodrug mixture contains a preheated fusion protein,comprising heat shock protein, glucose-regulated protein and immuogens; antigrowth agents; cancer, tuberculosis infection |
| 01/10/2006 | US6984382 Bifunctional protein, preparation and use |
| 01/10/2006 | CA2158357C Purification and molecular cloning of eg iii cellulase |
| 01/10/2006 | CA2114353C Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| 01/05/2006 | WO2004078146A3 Trans-membrane-antibody induced inhibition of apoptosis |
| 01/05/2006 | WO2003087338A3 Her-2 receptor tyrosine kinase molecules and uses thereof |
| 01/05/2006 | US20060003420 Monomeric and dimeric fluorescent protein variants and methods for making same |
| 01/05/2006 | US20060002946 Targeted immunogens |
| 01/05/2006 | US20060002941 Compositions comprising immune response altering agents and methods of use |
| 01/05/2006 | CA2572015A1 Fc-interferon-beta fusion proteins |
| 01/05/2006 | CA2470922A1 Cassette-based strategy for engineering multiple domain fusion proteins |
| 01/04/2006 | EP1612272A2 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 01/04/2006 | EP1612268A1 Receptor ligand VEGF-C |
| 01/04/2006 | EP1612223A2 Polypeptides with FC binding ability |
| 01/04/2006 | EP1053325B1 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| 01/04/2006 | EP0923606B1 Antigenic fusionprotein carrying galalpha1,3gal epitopes |
| 01/04/2006 | EP0804609B1 NOVEL p53 RESPONSE GENES |
| 01/04/2006 | CN1717417A Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases |
| 01/04/2006 | CN1234855C Recombinant Flt3 ligand gene and its fusion gene and product |
| 01/04/2006 | CN1234731C Human erythropoietin Fc fusion protein with high bioactivity |
| 01/04/2006 | CN1234730C Mouse antichloromycetin monoclonal antibody and its use |
| 01/04/2006 | CN1234729C Protein cross linking agent and method therefor |
| 01/04/2006 | CN1234411C Anti-tumor medicine |
| 12/29/2005 | WO2005028614A3 Construction of a gst-cbd fusion protein having several enzymatic activities |
| 12/29/2005 | WO2003012122A3 Crystallized structure of type iv collagen nc1 domain hexamer |
| 12/29/2005 | US20050288212 Components of the presenilin-complex |
| 12/29/2005 | US20050287648 Protein Transducing Domain/Deaminase Chimeric Proteins, Related Compounds, and Uses Thereof |
| 12/29/2005 | US20050287642 Efficient protein expression system |
| 12/29/2005 | US20050287635 RTD receptor |
| 12/29/2005 | US20050287530 TCL-1b gene and protein and related methods and compositions |
| 12/29/2005 | US20050287164 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections |
| 12/29/2005 | CA2735315A1 Plastid transit peptides |
| 12/29/2005 | CA2734716A1 Plastid transit peptides |
| 12/29/2005 | CA2734624A1 Plastid transit peptides |
| 12/29/2005 | CA2734561A1 Plastid transit peptides |
| 12/28/2005 | EP1609863A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/28/2005 | EP1609853A1 Process for controlling sialylation of proteins produced by mammalian cell culture |
| 12/28/2005 | EP1608730A2 Truncated baff receptors |
| 12/28/2005 | EP1608404A2 Methods and means to suppress symptons of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18) |
| 12/28/2005 | EP1507852A4 Nucleic acids and proteins with thioredoxin reductase activity |
| 12/28/2005 | EP1364029B1 FUSION PROTEIN comprising hirudin and proinsulin or insulin |
| 12/28/2005 | EP1123114B1 Virus-like particles for the induction of autoantibodies |
| 12/28/2005 | EP1085909B1 A complex of alpha-fetoprotein (AFP) and a polyunsaturated fatty acid derivative for the treatment of immune deficiencies |
| 12/28/2005 | EP1025227B1 Human toll homologues |
| 12/28/2005 | EP0646175B1 Recombinant pseudomonas exotoxin with increased activity |
| 12/28/2005 | EP0642585B1 Activation of oligomerizing receptors by using fused receptor ligands |
| 12/28/2005 | CN1712416A Anti-HIV fusogenic peptide and its production |
| 12/28/2005 | CN1712415A Connexin transduction structural domain and bioactive protein of auxiliary protein, its production and use |
| 12/28/2005 | CN1233659C Human granulocyte-macrophage colony stimulating factor/interleukin-6 fusion protein and its construction process |
| 12/27/2005 | US6979726 Immunoconjugates |
| 12/27/2005 | US6979446 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections |
| 12/27/2005 | CA2137280C Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications |
| 12/22/2005 | WO2005120552A1 METHODS AND FORMULATIONS OF GnRH/LEUKOTOXIN CHIMERAS FOR TESTOSTERONE SUPPRESSION |
| 12/22/2005 | WO2004070004A3 Rat receptor tyrosine kinase, kdr |
| 12/22/2005 | US20050282999 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same |
| 12/22/2005 | US20050282256 Adipocyte complement related protein zacrp13 |
| 12/22/2005 | US20050281831 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors |
| 12/21/2005 | EP1607402A1 Method for the diagnosis of tumour |
| 12/21/2005 | EP1606319A2 Treatment of viral infections |
| 12/21/2005 | EP1606318A2 Improved fc fusion proteins |
| 12/21/2005 | EP1605893A2 Trans-membrane-antibody induced inhibition of apoptosis |
| 12/21/2005 | EP1222200B1 Fusion protein between HPV-L1 and a peptide, capable of forming a VLP and that functions as a vehicle for introduction of a peptide in a cell and medical uses thereof |
| 12/21/2005 | EP1196442B1 Vgf polypeptides and methods of treating vgf-related disorders |
| 12/21/2005 | CN1709912A Multi-helix protein for inhibiting membrane virus infection, its coding gene and use |
| 12/21/2005 | CN1709911A Fusion protein of single antibody-interleukin 2, its preparation and use |
| 12/21/2005 | CN1232537C Heavy chain variable region single domain antibody reinforced fusion protein VH-LDP-AE |
| 12/21/2005 | CN1232536C Human stem cell factor macrophage colony stimulating factor bifunction protein and its preparation |
| 12/21/2005 | CN1232535C GST fusion expression of conotoxin MVII A gene and its use |
| 12/21/2005 | CN1232534C Heteroprotein of melanoma EPI (Mage-1, HLA-Al) and bacteriophage coat protein and its application |
| 12/20/2005 | US6977144 Nucleic acids encoding Selected Interacting Domain (SID registered) polypeptides binding selectively to a peptide encoded by a pathogenic strain of the hepatitis C virus; genetic engineering; gene therapy; bactericides; |
| 12/15/2005 | WO2005118817A1 Method for high speed screening for the identification of molecules inhibiting the activity of editing enzymes |
| 12/15/2005 | WO2005118647A2 M13 virus major coat protein variants for c-terminal and bi-terminal display of a heterologous protein |
| 12/15/2005 | WO2005118631A1 Novel protein complex and use thereof |
| 12/15/2005 | WO2005107785A3 Human complement c3 derivates with cobra venom factor-like function |
| 12/15/2005 | WO2005090570A9 Therapeutic compositions and methods for treating diseases that involve angiogenesis |
| 12/15/2005 | WO2004096989A9 Single chain antigen-binding polypeptides for polymer conjugation |
| 12/15/2005 | WO2003062370A3 Multimeric proteins and methods of making and using same |
| 12/15/2005 | WO2003029409A3 Methods for generating, selecting, and identifying compounds which bind a target molecule |
| 12/15/2005 | WO2002083855A3 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 12/15/2005 | US20050277575 Therapeutic compositions and methods for treating diseases that involve angiogenesis |
| 12/15/2005 | US20050277160 peptide or a phage recognizing nanographite structures and thus enabling efficient recognition, binding, separation and alignment of nanographite structures such as carbon nanohorns or carbon nanotubes, an artificial protein or a chimeric molecule comprising the above-described peptide bond |
| 12/15/2005 | CA2563930A1 Method for activating of t cell protein tyrosine phosphatase and therapeutical methods based thereon |
| 12/14/2005 | EP1605055A1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 12/14/2005 | EP1605054A1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 12/14/2005 | EP1605052A2 A method for producing influenza hemagglutinin multivalent vaccines |
| 12/14/2005 | EP1603951A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies |
| 12/14/2005 | EP1280904B1 Pain signaling molecules |
| 12/14/2005 | EP1007666B1 Neurturin receptor |
| 12/14/2005 | CN1706867A Angiogenesis inhibiting fusion protein and its use |